Biotech

All Articles

Gene editor Volume laying off 131 employees

.Just times after gene publisher Volume Biosciences introduced confidential working slices, a more c...

Repare lays off 25% of personnel as biotech stops preclinical R&ampD

.Repare Therapy is actually giving up a quarter of its own workforce as the oncology biotech downsiz...

J &amp J apply for FDA confirmation of $6.5 B autoimmune drug

.Johnson &amp Johnson has taken one more measure towards understanding a profit on its $6.5 billion ...

Gain's stage 1 win leads method to show Parkinson's drug's worth

.Gain Therapeutics has prepared its sights on confirming the efficiency of its Parkinson's condition...

Actinogen records brand new period 2 data to salvage anxiety drug

.Actinogen Medical's hopes-- as well as supply cost-- have rebounded somewhat from earlier this mont...

Pfizer and also Flagship include Quotient to multibillion-dollar equation

.Flagship Pioneering and Pfizer have incorporated Quotient into their 10-program alliance, inking a ...

Bayer pens $547M deal to press boundaries of noncoding RNA

.Bayer executives were eager to anxiety to Intense this summer that the German pharma titan's appeti...

UK reveals plannings to release 18 new medical test hubs

.Amidst a yearslong scientific trial downtrend in the U.K., a brand new public-private partnership h...

UPDATE: Genentech telegrams 93 cutbacks in The golden state after sharing strategies to shutter cancer cells immunology study unit

.Adhering to the statement of a large unemployment shot in April as well as a significant restructur...

Neurocrine's KarXT competitor hits in period 2-- but merely at reduced dose

.Neurocrine Biosciences has accomplished its hoped-for profile page in a phase 2 schizophrenia test,...